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Abstract
Objectives: Respondent-driven sampling (RDS) is a new data collection methodology used to estimate characteristics of hard-to-reach
groups, such as the HIV prevalence in drug users. Many national public health systems and international organizations rely on RDS data.
However, RDS reporting quality and available reporting guidelines are inadequate. We carried out a systematic review of RDS studies and
present Strengthening the Reporting of Observational Studies in Epidemiology for RDS Studies (STROBE-RDS), a checklist of essential
items to present in RDS publications, justified by an explanation and elaboration document.
Study Design and Setting: We searched the MEDLINE (1970e2013), EMBASE (1974e2013), and Global Health (1910e2013)
databases to assess the number and geographical distribution of published RDS studies. STROBE-RDS was developed based on STROBE
guidelines, following Guidance for Developers of Health Research Reporting Guidelines.
Results: RDS has been used in over 460 studies from 69 countries, including the USA (151 studies), China (70), and India (32).
STROBE-RDS includes modifications to 12 of the 22 items on the STROBE checklist. The two key areas that required modification con-
cerned the selection of participants and statistical analysis of the sample.
Conclusion: STROBE-RDS seeks to enhance the transparency and utility of research using RDS. If widely adopted, STROBE-RDS
should improve global infectious diseases public health decision making.  2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Hidden or hard-to-reach population subgroups are often
key to the maintenance of infectious diseases in human
populations [1]. However, it is often difficult to investigate
the factors that drive transmission in these groups by using
commonly used epidemiologic methods of data collection
because of the lack of an adequate sampling frame [2].
Researchers have therefore typically resorted to various
types of convenience sampling to gather data on hidden
populations [3]. Although convenience sampling has its
advantages, this approach is unable to generate unbiased
population-based estimates of infection prevalence and risk
factors. In an attempt to address these limitations,
respondent-driven sampling (RDS), a variant of a link-
tracing design, was proposed in 1997 [4].
RDS studies are characterized by both a specific data
collection method and specific statistical analysis methods.
Key features of the data collection include: (1) a small pro-
portion of the sample is recruited by the researcher (i.e., the
‘‘seeds’’) and a large proportion of the sample is recruited
(in recruitment ‘‘waves’’) by other members of the target
population to whom they have a social relationship; (2)
recording of recruitment connections between respondents
(e.g., who recruited whom); (3) the maximum number of
people that each participant can recruit is determined by
the researcher by giving out a limited number of recruit-
ment ‘‘coupons’’; (4) respondents are compensated for
participating in the study and recruiting others into the
study. Collectively, these features often make RDS an effi-
cient data collection method [5]. Although often efficient,
the RDS data collection method produces multiple chal-
lenges for the analysis. First, because most of the sampling
is conducted by respondents, assumptions about the sam-
pling process are needed. Second, under a variety of
assumptions, not all members of the target population will
have the same probability of selection, so this probability is
typically estimated using a combination of modeling
assumptions and study data. Finally, because sampling hap-
pens through pre-existing relationships, the observations
are not independent. These challenges make point and vari-
ance estimation from RDS data more complex than from
other forms of sampling. Numerous approaches have been
developed, and more are currently under development
[6e12].
Since its introduction in 1997 [4], there has been a rapid
increase in the number of surveys of hidden or hard-
to-reach populations using the RDS methodology, primarily
of individuals at risk of sexually or parenterally transmitted
infections including HIV [5,13], but also on topics as
diverse interpersonal violence [13] and strategies for
improving cancer screening recruitment [14]. Many coun-
tries including the United States, Ukraine, Vietnam,
Mauritius, Morocco, and Brazil use RDS as part of their
national public health systems, and data from RDS studies
are used by major public health organizations including the
US Centers for Disease Control and Prevention, the Joint
United Nations Programme on HIV/AIDSs, and the Global
Fund to Fight AIDS, Tuberculosis and Malaria. The
National Institutes of Health alone has awarded around
$100 million in funding to projects using RDS and its var-
iants [15].
Making sense of the rapidly increasing amount of data
collected using RDS [5,16] is crucial to the integration of
this information into the practice of medicine and public
health. However, the assessment of the strengths and
weaknesses of RDS data and methods has been limited
by the inadequate reporting of RDS studies. An assess-
ment of 22 randomly selected RDS studies has recently
been carried out [17]. The assessment found that overall
only around one-third of items sought were reported. Key
details of the sampling and statistical methods were
particularly poorly reported, including the methods of
seed selection (reported in 45% of studies), the number
of recruits from each seed and number of recruits in each
recruitment wave (33%), the details of the recruitment
venues (33%), eligibility criteria for seeds (!20%),
wording of network size questions (!20%), if seeds
were included in the analysis (!20%), how participants
were trained to recruit others (0%), and an explanation
for differences between unadjusted and adjusted
estimates (0%) [17].
To improve the quality of reporting of observational
epidemiologic studies, the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) state-
ment [18e21] and extensions [22,23] were developed.
However, the STROBE statement is inadequate for report-
ing RDS studies because of the major differences in the
RDS sampling and estimation procedures. Our aims are
to present a systematic review of the number of RDS
studies and present the ‘‘STROBE-RDS’’ statement, a
checklist of essential items to present in RDS publications,
justified and supported by a stand-alone explanation and
elaboration document.
2. Methods
2.1. Systematic literature review of RDS studies
A systematic literature review was carried out purely to
assess the number of published RDS studies and summa-
rize their geographical distribution. Briefly, we searched
the MEDLINE (1970e2013), EMBASE (1974e2013),
and Global Health (1910e2013) databases and asked ex-
perts for their collections of relevant articles. Studies con-
ducted in any country, in any language, among any study
population were included; reviews, editorials, commen-
taries, and methodological articles were excluded. A previ-
ous assessment had identified the inadequacy of previous
RDS reporting [17], and therefore, further details on
RDS reporting were not collected. Full details are shown
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What is new?
Key findings
 Strengthening the Reporting of Observational
Studies in Epidemiology for respondent-driven
sampling studies (STROBE-RDS) was developed
based on STROBE statement following published
Guidance for Developers of Health Research Re-
porting Guidelines. The STROBE-RDS checklist
includes modifications to 12 of the 22 items on
the STROBE checklist. The two key areas that
required modification concerned the selection of
participants and the statistical analysis of the
sample.
What this adds to what was known?
 Respondent-driven sampling (RDS) is a new data
collection methodology used to estimate character-
istics of hard-to-reach groups, such as the HIV
prevalence in drug users. Many national public
health systems and international organizations rely
on RDS data. RDS reporting quality and available
reporting guidelines are inadequate. STROBE-
RDS is a checklist of essential items to present in
RDS publications.
What is the implication and what should change
now?
 The STROBE-RDS statement seeks to enhance the
transparency and utility of research using RDS. If
widely adopted, the STROBE-RDS checklist
should improve public health decision making in
infectious diseases.
in the Supplementary Material (Document 1 at www.
jclinepi.com).
2.2. Statement development
The STROBE-RDS statement was developed after the
Guidance on Health Research Guidelines of Moher et al
[24]. The initial need for the RDS reporting guidelines was
identified in RDS expert and stakeholder discussions at an
RDS symposium in 2011 [25]. This was followed by a system-
atic evaluation of the reporting of RDS studies that concluded
that the reportingofRDSstudieswas inadequate [17]. Existing
guidelines were then reviewed, and the most suitable was the
STROBE statement [18,19], but this was assessed to be inad-
equate for reporting RDS studies because of the major differ-
ences in the RDS sampling and estimation procedures. The
vast majority of existing RDS studies use a cross-sectional
study design. Therefore, this statement is an extension of the
STROBE guidelines [18], the STROBE explanation and
elaboration document [19], and the STROBE checklist for
cross-sectional studies [20]. Version 1 of the STROBE-RDS
checklist was distributed for consultation by posting on the
Equator Network Web site [26] and the RDS listserv [27]
and by sending to known experts. Themes emerging from
the feedback included: strong support for the initiative and a
request to restrict the scope of the guidelines to cross-
sectional epidemiologic studies that seek to generate represen-
tative estimates for the target population. The checklist was
revised based on this feedback, and version 2 was published
in early October 2012 [28]. Version 2 of the checklist was pi-
loted during October 2012 by using it to guide manuscript
drafting and was sent to the STROBE group for feedback
[18]. Researchers (n5 5) piloting the checklist providedmuch
useful feedback and requested a stand-alone checklist and sup-
porting document. This and other feedback was used to
develop version 3 of the checklist, which was discussed at a
2-day face-to-face meeting in New Orleans in October 2012
[29]. A list of potential meeting invitees was drawn up by a
subset of coauthors (R.G.W.,A.J.H., andW.H.) after consulta-
tion with STROBE initiative members, statisticians, epidemi-
ologists, and empirical RDS researchers. Potential invitees
were categorized into three groups: statisticians/survey meth-
odologists, epidemiologists/empirical RDS researchers, and
journal editors. Fifty percent (2 of 4), 46% (6 of 13), and 0%
(0 of 2), respectively, of meeting invitees in these three groups
participated (11 meeting attendees in total). Participants were
sent the draft checklist, a summary of the previousRDS report-
ing [17] and the guidelines by Moher et al. [24]. At the
meeting, eachdraft checklist itemwaspresented anddiscussed
in turn and edited on screen in real time until agreement on the
final version of the checklist was reached by consensus and is
presented in thismanuscript. Consensus was defined as asking
verbally all participants if they agreed to the written text for
each item. There were no items on which consensus was not
reached during the meeting. After the face-to-face meeting,
this summary manuscript was drafted by the authors, and to
accompany the checklist, an ‘‘Explanation and Elaboration’’
document was developed and revised based on feedback from
experts and the STROBE group and is presented in the
Supplementary Material (Document 2 at www.jclinepi.com).
2.3. Statement scope
The scope of the ‘‘STROBE-RDS’’ statement is limited
to (1) epidemiologic studies (the scope of the original
STROBE guidelines), (2) cross-sectional studies (the most
common RDS study design to date), and (3) RDS studies
that seek to generate representative estimates for the target
population (currently the most contentious and potentially
most policy-relevant use of RDS). Furthermore, as RDS
is both a sampling and a data analysis method, guidelines
for reporting on both aspects of RDS are provided. Finally,
in response to feedback from researchers piloting the
STROBE-RDS checklist, we aim to provide a self-
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contained statement that minimizes the need to refer to
other documents when reporting on an RDS study.
3. Results
The systematic literature review and input from experts
identified that globally over 460 peer-reviewed publica-
tions have reported using RDS since the mid-1990s, with
most published since 2006 (Fig. 1A). Fig. 1B shows the
global distribution of study locations. RDS studies have
been conducted in 69 countries, including the United
States of America (151 studies), China (70), India (32),
Mexico (22), and South Africa (16). The articles came
from 141 different journals. Most journals (91) had pub-
lished either one or two articles included in the review.
Nine journals had published 10 or more articles (or con-
ference abstracts). Supplementary Material (Document 1
at www.jclinepi.com) provides more details of review
methods, results, and included and excluded articles.
In Table 1, we present the proposed STROBE-RDS
statement checklist, a modification of the STROBE state-
ment checklist for cross-sectional studies [20]. The left col-
umn lists the original STROBE checklist for cross-sectional
studies. The right column summarizes the reporting recom-
mendation. A three-column version of the checklist, high-
lighting the changes from the original STROBE checklist,
is shown in the supplementary information, along with an
explanation and elaboration document [Supplementary
Material (Document 2 at www.jclinepi.com)]. As there is
considerable variation in the use of terms and definitions
across the disciplines in which RDS is used, we also present
a list of suggested RDS terms and definitions to be used
when reporting RDS studies (Box 1).
The STROBE-RDS checklist provides modifications to
12 of the 22 items on the STROBE checklist. The two
key areas requiring modification concerned the selection
of participants and the statistical analysis of the sample.
These modifications are summarized below.
3.1. Selection of participants
As members of the target population, not researchers,
recruit most study participants in RDS studies, details of
the formative research conducted before the study (T5b)
and of how participants were trained to recruit others (6a)
should be reported. Key details of the recruitment process
should also be reported, including the number of coupons
issued per person, any time limits for referral (6a), proce-
dures of seed selection (6b), the exact wording of personal
network size question(s) (6d), the incentives for participa-
tion and recruitment (6e), and how the recruitererecruit
relationship was tracked (7b). Variation in study procedures
during data collection should also be reported (6c).
Methods to assess eligibility and reduce repeat enrollment
should be described (8b) so that other researchers can
understand the data collection process and any biases it
might introduce. Authors should report reasons for nonpar-
ticipation at each stage (e.g., not eligible, does not consent,
decline to recruit others) (13b), the number of coupons
issued and returned (13d), the number of recruits by seed
and number of recruitment waves for each seed (13e),
any recruitment challenges (e.g., commercial exchange of
coupons, imposters, duplicate recruits), and how they were
addressed (13f) (Table 1, items 5b, 6a,b,c,d,e, 7b, 8b,
13b,d,e,f).
3.2. Statistical analysis
Several different estimators exist for estimating the
prevalence of a specific trait (e.g., HIV prevalence) from
RDS data [6e12]. There are also a number of different
methods for producing confidence intervals around these
estimates [8,30e32]. Evaluations of these methods have
been equivocal [33e35], and the best estimator may
depend on specific features of a study [36]. At this time,
there is no consensus that one estimator should be univer-
sally used. As such, we recommend authors clearly
describe the statistical methods used, including those to
Fig. 1. (A) Number of published peer-reviewed studies using respondent-driven sampling 1990eJuly 2013. * 5 part year. (B) World map showing
number of published peer-reviewed studies using respondent-driven sampling 1990eJuly 2013, by country.
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Table 1. STROBE-RDS Statement Checklist
Item # Original STROBE checklist for cross-sectional studies STROBE-RDS checklist
Title and abstract 1 (a) Indicate the study’s design with a commonly used term
in the title or the abstract
(a) Indicate ‘‘respondent-driven sampling’’ in the title or
abstract
(b) Provide in the abstract an informative and balanced
summary of what was done and what was found
(b) Provide in the abstract an informative and balanced
summary of what was done and what was found
Introduction
Background/
rationale
2 Explain the scientific background and rationale for the
investigation being reported
Explain the scientific background and rationale for the
investigation being reported
Objectives 3 State specific objectives, including any prespecified
hypotheses
State-specific objectives, including any prespecified
hypotheses
Methods
Study design 4 (a) Present key elements of study design early in the
article
(a) Present key elements of study design early in the
article
(b) State why RDS was chosen as the sampling method
Setting 5 (a) Describe the setting, locations, and relevant dates,
including periods of recruitment, exposure, follow-up,
and data collection
(a) Describe the setting, locations, and relevant dates,
including periods of recruitment and data collection
(b) Describe formative research findings used to inform
RDS study
Participants 6 (a) Give the eligibility criteria and the sources and
methods of selection of participants
(a) Give the eligibility criteria and the sources and
methods of selection of participants. Describe how
participants were trained/instructed to recruit others,
number of coupons issued per person, any time limits
for referral
(b) Describe methods of seed selection and state number
at start of study and number added later
(c) State if there was any variation in study procedures
during data collection (e.g., changing numbers of
coupons per recruiter, interruptions in sampling, or
stopping recruitment chains)
(d) Report wording of personal network size question(s)
(e) Describe incentives for participation and recruitment
Variables 7 (a) Clearly define all outcomes, exposures, predictors,
potential confounders, and effect modifiers. Give
diagnostic criteria, if applicable
(a) If applicable, clearly define all outcomes, correlates,
predictors, potential confounders, effect modifiers, and
diagnostic criteria
(b) State how recruitererecruit relationship was tracked
Data sources/
measurement
8 (a) For each variable of interest, give sources of data and
details of methods of assessment (measurement).
Describe comparability of assessment methods if there
is more than one group
(a) For each variable of interest, give sources of data and
details of methods of measurement. Describe
comparability of measurement methods if there is more
than one group
(b) Describe methods to assess eligibility and reduce
repeat enrollment (e.g., coupon manager software,
biometrics)
Bias 9 Describe any efforts to address potential sources of bias Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at Explain how the study size was arrived at
Quantitative
variables
11 Explain how quantitative variables were handled in the
analyses. If applicable, describe which groupings were
chosen and why
Explain how quantitative variables were handled in the
analyses. If applicable, describe which groupings were
chosen and why
Statistical
methods
12 (a) Describe all statistical methods, including those used
to control for confounding
(a) Describe all statistical methods, including those to
account for sampling strategy (e.g., the estimator used)
and, if applicable, those used to control for confounding
(b) State data analysis software, version number, and
specific analysis settings used
(b) Describe any methods used to examine subgroups and
interactions
(c) Describe any methods used to examine subgroups and
interactions
(c) Explain how missing data were addressed (d) Explain how missing data were addressed
(d) If applicable, describe analytical methods taking
account of sampling strategy
(e) Describe any sensitivity analyses (e) Describe any sensitivity analyses
(f) Report any criteria used to support statements on
whether estimator conditions or assumptions were
appropriate
(g) Explain how seeds were handled in analysis
(Continued )
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Table 1. Continued
Item # Original STROBE checklist for cross-sectional studies STROBE-RDS checklist
Results
Participants 13 (a) Report the numbers of individuals at each stage of the
studydfor example, numbers potentially eligible,
examined for eligibility, confirmed eligible, included in
the study, completing follow-up, and analyzed
(a) Report the numbers of individuals at each stage of the
studydfor example, numbers potentially eligible,
examined for eligibility, confirmed eligible, included in
the study, and analyzed
(b) Give reasons for nonparticipation at each stage (b) Give reasons for nonparticipation at each stage (e.g.,
not eligible, does not consent, decline to recruit others)
(c) Consider use of a flow diagram (c) Consider use of a flow diagram
(d) Report number of coupons issued and returned
(e) Report number of recruits by seed and number of RDS
recruitment waves for each seed. Consider showing
graph of entire recruitment network
(f) Report recruitment challenges (e.g., commercial
exchange of coupons, imposters, duplicate recruits) and
how addressed
(g) Consider reporting estimated design effect for
outcomes of interest
Descriptive data 14 (a) Give characteristics of study participants (e.g.,
demographic, clinical, social) and information on
exposures and potential confounders
(a) Give characteristics of study participants (e.g.,
demographic, clinical, social) and, if applicable,
information on correlates and potential confounders.
Report unweighted sample size and percentages,
estimated population proportions or means with
estimated precision (e.g., 95% confidence interval)
(b) Indicate the number of participants with missing data
for each variable of interest
(b) Indicate the number of participants with missing data
for each variable of interest
Outcome data 15 Report numbers of outcome events or summary measures If applicable, report number of outcome events or
summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable,
confounder-adjusted estimates and their precision (e.g.,
95% confidence intervals). Make clear which
confounders were adjusted for and why they were
included
(a) Give unadjusted and study designeadjusted estimates
and, if applicable, confounder-adjusted estimates and
their precision (e.g., 95% confidence intervals). Make
clear which confounders were adjusted for and why they
were included
(b) Report category boundaries when continuous variables
were categorized
(b) Report category boundaries when continuous variables
were categorized
(c) If relevant, consider translating estimates of relative
risk into absolute risk for a meaningful period
(c) If adjustment of primary outcome leads to marked
changes, report information on factors influencing the
adjustments (e.g., personal network sizes, recruitment
patterns by group, key confounders)
Other analyses 17 Report other analyses donedfor example, analyses of
subgroups and interactions and sensitivity analyses
Report other analyses donedfor example, analyses of
subgroups and interactions, sensitivity analyses,
different RDS estimators and definitions of personal
network size
Discussion
Key results 18 Summarize key results with reference to study objectives Summarize key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account
sources of potential bias or imprecision. Discuss both
direction and magnitude of any potential bias
Discuss limitations of the study, taking into account
sources of potential bias or imprecision. Discuss both
direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other
relevant evidence
Generalizability 21 Discuss the generalizability (external validity) of the study
results
Discuss the generalizability (external validity) of the study
results
Other information
Funding 22 Give the source of funding and the role of the funders for
the present study and, if applicable, for the original
study on which the present article is based
Give the source of funding and the role of the funders for
the present study and, if applicable, for the original
study on which the present article is based
Abbreviations: STROBE-RDS, Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling;
#, number.
Italics highlight changes from STROBE statement checklist for cross-sectional studies [20]. Full details of modifications from [20] are shown in
Table S1 in Supplementary Material at www.jclinepi.com.
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adjust for sample design, both when making estimates
(Table 1, 12a,b) and when quantifying the uncertainty in
those estimates (16a,c). As the utility of the various
RDS estimators is unknown, we recommend reporting un-
adjusted and study designeadjusted estimates and, if
applicable, confounder-adjusted estimates and their preci-
sion (16a). If adjustment of the primary outcome leads to
marked changes, information on factors causing the
changes (e.g., personal network sizes, recruitment patterns
by group, key confounders) should be reported (16c)
(Table 1, items 12a,b, 16a,c).
4. Discussion
The STROBE-RDS statement is a checklist of essential
items that should be reported in RDS studies. The statement
has several strengths. It is based on existing guidance for
reporting observational studies, [18e20] was developed
by an interdisciplinary group that included epidemiologists,
statisticians, and empirical RDS researchers, and explicitly
justifies changes from the original STROBE statement.
The decisions made for the conduct and data analysis of
RDS studies will influence the representativeness of a
study’s results. The empirical evidence on how representa-
tive the study results are is limited, and improving the
methodology is an active research area. Transparent report-
ing is essential for developing a better evidence base and
improving RDS methods.
Based on feedback we received from researchers
writing up RDS studies during the piloting of earlier ver-
sions of this checklist [28], we decided to provide a stand-
alone STROBE-RDS checklist with full supporting docu-
mentation, rather than only providing a modified STROBE
checklist. This should mean that researchers writing up
RDS studies will be more likely to use these reporting
guidelines. We encourage readers to read the accompa-
nying explanation and elaboration document in full
(supporting material) before embarking on writing up an
RDS study.
The statement can be used by authors, peer reviewers,
and editors to improve the reporting of RDS studies. We
invite journals to endorse STROBE-RDS, and although
STROBE-RDS will be published in English only once,
Box 1 Respondent-driven sampling key terms and definitions
Candidate participantda coupon recipient who attempts to enroll in the study.
Coupondan invitation to enroll in the RDS study that a participant can give to other people.
Coupon recipientda person who receives a coupon.
Equilibriumdthis term has inconsistent usage in the RDS community. The most common usage is that the observed
sample composition matches the expected long-run sample composition assuming a specific model of the sampling
process.
Follow-up interviewdan interview where additional information is collected from the subset of participants who
return to the study site a second time to collect recruitment incentives and/or biological test results.
Homophilydthis term has inconsistent usage in the RDS community. Sometimes it is used to refer to the tendency
for sample recruitments to occur between participants in the same social category and sometimes to refer to the
tendency for relationships in the target population to occur between participants in the same social category.
Main interviewdinterview that is conducted of all participants where the main study information is collected.
Participantsdmembers of the target population who have provided consent and completed the main interview.
Participation incentivedthe money, goods, and/or services provided to participants for completing the main
interview.
Peer-recruited participantda participant recruited by a member of the target population.
Personal network size (also called ‘‘degree’’)dthe number of relationships a person has to members of the target
population.
Population estimatedan estimate of a characteristic of the study population that takes into account the RDS
sampling design.
Recruitment incentivedthe money, goods, and/or services provided to participants for each new participant they
are able to recruit.
Recruitment tree (also chain)dthe set of all participants linked to a specific seed.
Sample descriptionda summary statistic of participants that does not take into account the RDS sampling design.
Screening interviewda short initial interview with people hoping to enroll in the study that seeks to verify mem-
bership in the target population and request consent.
Seedda participant who is recruited by a researcher.
Target populationdthe set of people about whom the researchers wish to make estimates.
Wavedthe set of participants a given number of recruitments from a seed.
Abbreviation: RDS, respondent-driven sampling.
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we invite others to translate STROBE-RDS and to submit
commentaries, editorials, or use other means to raise the
awareness of the STROBE-RDS publication. The ability
to provide information in Web supplements should alleviate
concerns about the increased length of manuscripts result-
ing from following the guidelines. We welcome comments
directed to the corresponding author or via the journal or
Equator Network Web sites where the guidelines are also
deposited [26]. These will be used to update this
STROBE-RDS statement as RDS methods develop.
The STROBE-RDS statement does not prescribe or
dictate how an RDS study should be designed or analyzed.
Rather, it seeks to enhance the transparency of research
using RDS to increase the understanding of individual
studies and enable comparisons between studies. If widely
adopted, the STROBE-RDS checklist should improve
global public health decision making for infectious dis-
eases. Further studies could assess the impact of
STROBE-RDS on the transparency of RDS research and
on global public health decision making.
4.1. Search strategy and selection criteria
We searched published (physically published or online),
peer-reviewed literature accessible through July 2013 that
reported using RDS. Studies from all countries were
included. We conducted searches using MEDLINE
(1970e2013), EMBASE (1974e2013), and Global Health
(1910e2013). Search terms used included ‘‘respondent
driven’’ or ‘‘respondent-driven’’ or ‘‘RDS.’’
Supplementary data
Supplementary data related to this article can be found at
http://dx.doi.org/10.1016/j.jclinepi.2015.04.002.
References
[1] Anderson R, May R. Infectious diseases of humans: dynamics and
control. Oxford: Oxford University Press; 1991.
[2] Rothman KJ, Greeenland S. Modern epidemiology. 2nd ed. Philadel-
phia: Lippincott Williams & Williams; 1997.
[3] Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling
hard-to-reach and hidden populations for HIV surveillance. Aids
2005;19(Suppl 2):S67e72.
[4] Heckathorn DD. Respondent-driven sampling: a new approach to the
study of hidden populations. Social Probl 1997;44(2):174e99.
[5] Malekinejad M, Johnston L, Kendall C, Kerr L, Rifkin M,
Rutherford G. Using respondent-driven sampling methodology for
HIV biological and behavioral surveillance in international settings:
a systematic review. AIDS Behav 2008;12:105e30.
[6] Salganik MJ, Heckathorn DD. Sampling and estimation in hidden
populations using respondent-driven sampling. Sociol Methodol
2004;34(1):193e240.
[7] Heckathorn DD. Extensions of respondent-driven sampling:
analyzing continuous variables and controlling for differential
recruitment. Sociol Methodol 2007;37(1):151e207.
[8] Volz E, Heckathorn D. Probability based estimation theory for
respondent driven sampling. J Off Stat 2008;24(1):79e97.
[9] Gile KJ. Improved inference for respondent-driven sampling data
with application to HIV prevalence estimation. J Am Stat Assoc
2011;106:135e46.
[10] Gile KJ, Handcock MS. Network model-assisted inference from
respondent-driven sampling data. arXiv preprint arXiv:11080298 2011.
[11] Lu X, Malmros J, Liljeros F, Britton T. Respondent-driven sampling
on directed networks. Arxiv preprint arXiv:12011927 2012.
[12] McCreesh N, Copas A, Seeley J, Johnston LG, Sonnenberg P,
Hayes RJ, et al. Respondent driven sampling: determinants of recruit-
ment and a method to improve point estimation. PLoS One 2013;8:
e78402.
[13] Evans-Campbell T, Lindhorst T, Huang B, Walters KL. Interpersonal
violence in the lives of urban American Indian and Alaska Native
women: implications for health, mental health, and help-seeking.
Am J Public Health 2006;96:1416e22.
[14] Clark MA, Neighbors CJ, Wasserman MR, Armstrong GF,
Drnach ML, Howie SL, et al. Strategies and cost of recruitment of
middle-aged and older unmarried women in a cancer screening study.
Cancer Epidemiol Biomarkers Prev 2007;16(12):2605e14.
[15] Mouw T, Verdery AM. Network sampling with memory: a proposal
for more efficient sampling from social networks. Sociol Methodol
2012;42(1):206e56.
[16] Montealegre JR, Johnston LG, Murrill C, Monterroso E. Respon-
dent driven sampling for HIV biological and behavioral surveil-
lance in Latin America and the Caribbean. AIDS Behav 2013;17:
2313e40.
[17] Hafeez S. A review of the proposed STROBE-RDS reporting check-
list as an effective tool for assessing the reporting quality of RDS
studies from the developing world. London: LSHTM; 2012.
[18] von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC,
Vandenbroucke JP. The Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement: guidelines for report-
ing observational studies. Plos Med 2007;4:e296.
[19] Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the
Reporting of Observational Studies in Epidemiology (STROBE):
explanation and elaboration. Plos Med 2007;4:e297.
[20] STROBE. STROBE checklist for cross-sectional studies 2007: Avail-
able at http://www.strobe-statement.org/index.php?id5available-che
cklists Accessed June 13, 2015.
[21] von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC,
Vandenbroucke JP, et al. The Strengthening the Reporting of Obser-
vational Studies in Epidemiology (STROBE) statement: guidelines
for reporting observational studies. J Clin Epidemiol 2008;61:
344e9.
[22] Gallo V, Egger M, McCormack V, Farmer PB, Loannidis JP, Kirsch-
Volders M, et al. STrengthening the Reporting of OBservational
studies in EpidemiologyeMolecular Epidemiology STROBE-ME:
an extension of the STROBE statement. J Clin Epidemiol 2011;64:
1350e63.
[23] Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E,
et al. Strengthening the reporting of genetic association studies
(STREGA): an extension of the strengthening the reporting of obser-
vational studies in epidemiology (STROBE) statement. J Clin Epide-
miol 2009;62:597e608. 608.e4.
[24] Moher D, Schulz KF, Simera I, Altman DG. Guidance for devel-
opers of health research reporting guidelines. Plos Med 2010;7:
e1000217.
[25] White RG. Respondent-driven sampling: where we are and where we
are/should be going? 19th Biennial ISSTDR conference; 2011;
Quebec; 2011.
[26] Equator Network. Equator Network: Available at http://www.equator-
network.org/reporting-guidelines/strobe-rds/ Accessed June 13, 2015.
[27] RDS list server. Available at (respdrivensampling@Princeton.edu).
RESPDRIVENSAMPLING@Princeton.EDU.
[28] White RG, Lansky A, Goel S, Wilson D, Hladik W, Hakim A, et al.
Respondent driven samplingdwhere we are and where should we be
going? Sex Transm infect 2012;88:397e9.
8 R.G. White et al. / Journal of Clinical Epidemiology - (2015) -
[29] Strengthening the reporting of observational studies in epidemiology:
respondent driven sampling surveys: STROBE-RDS. 2012. New
Orleans: Tulane University School of Public Health and Tropical
Medicine; 2012:(29-30th Oct 2012).
[30] Salganik MJ. Variance estimation, design effects, and sample size
calculations for respondent-driven sampling. J Urban Health 2006;
83:i98e112.
[31] Szwarcwald CL, de Souza Junior PR, Damacena GN, Junior AB,
Kendall C. Analysis of data collected by RDS among sex workers in
10 Brazilian cities, 2009: estimation of the prevalence of HIV, variance,
and design effect. J Acquir Immune Defic Syndr 2011;57:S129e35.
[32] Weir SS, Merli MG, Li J, Gandhi AD, Neely WW, Edwards JK, et al.
A comparison of respondent-driven and venue-based sampling of
female sex workers in Liuzhou, China. Sex Transm infect 2012;88:
i95e101.
[33] McCreesh N, Frost SDW, Seeley J, Katongole J, Tarsh MN,
Ndunguse R, et al. Evaluation of respondent-driven sampling. Epide-
miology 2012;23:138e47.
[34] Goel S, Salganik MJ. Assessing respondent-driven sampling. Proc
Natl Acad Sci U S A 2010;107:6743e7.
[35] Wejnert C. An empirical test of respondent-driven sampling: point es-
timates, variance, degree measures, and out-of-equilibrium data.
Sociol Methodol 2009;39(1):73e116.
[36] Tomas A, Gile KJ. The effect of differential recruitment, non-
response and non-recruitment on estimators for respondent-driven
sampling. Electron J Stat 2011;5:899e934.
9R.G. White et al. / Journal of Clinical Epidemiology - (2015) -
